Menu Search
Equities

ConvaTec Group PLC

CTEC:LSE

ConvaTec Group PLC

Actions
Health CareMedical Equipment and Services
  • Price (GBX)226.60
  • Today's Change-5.40 / -2.33%
  • Shares traded2.48m
  • 1 Year change+2.53%
  • Beta0.6053
Data delayed at least 20 minutes, as of Sep 18 2024 16:35 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year ConvaTec Group PLC grew revenues 3.37% from 2.07bn to 2.14bn while net income improved 107.15% from 62.90m to 130.30m.
Gross margin55.96%
Net profit margin6.96%
Operating margin13.29%
Return on assets4.15%
Return on equity9.34%
Return on investment4.74%
More ▼

Cash flow in USDView more

In 2023, cash reserves at ConvaTec Group PLC fell by 46.20m. However, the company earned 367.40m from its operations for a Cash Flow Margin of 17.15%. In addition the company used 285.70m on investing activities and also paid 124.00m in financing cash flows.
Cash flow per share0.1374
Price/Cash flow per share16.84
Book value per share0.6135
Tangible book value per share-0.1866
More ▼

Balance sheet in USDView more

ConvaTec Group PLC has a Debt to Total Capital ratio of 46.04%, a lower figure than the previous year's 88.85%.
Current ratio2.26
Quick ratio1.27
Total debt/total equity0.8532
Total debt/total capital0.4604
More ▼

Growth rates in USD

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 9.77% and 105.90%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth ranked highest relative to its industry peers, while earnings per share growth is in-line with the industry average.
Div yield(5 year avg)2.19%
Div growth rate (5 year)31.41%
Payout ratio (TTM)61.55%
EPS growth(5 years)-7.80
EPS (TTM) vs
TTM 1 year ago		117.35
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.